
Clinical Utility of Serum Neuropeptide Q in Patients With Acute Coronary Syndrome: A Case-Control Observational Pilot Study
<a href="https://news.google.com/rss/articles/CBMi8wFBVV95cUxPeXRzdmZBTG4zdmpLWFJUWjdDWGtqNnp0WlZWMy1JUjR2cC1Kdnc4d2ZpSmNpb18xU2ZqYmg5UHZNeklzRm5tZ2NjaHdCZVVWMVpNS1pwTjBZbzN5QUtVWmRLdTdWRDAtb2tKMVFUaG1pcUdGdzZzZUpyMlFCeU90eXVSRmlDOUxqNDRRdkxQUlNUZGtEY0FtYmpKRVBFTG9ELU5vNXFJV1Q0S09KU3diV2kzMnBxNWFsSDNZaDNPeGt0clI5amJYX1ZoLWJwUlhyTFhmN3hPcXVzU3dhc0pDOWFIWU9uSVFZQTV4MG52aDhvbWs?oc=5" target="_blank">Clinical Utility of Serum Neuropeptide Q in Patients With Acute Coronary Syndrome: A Case-Control Observational Pilot Study</a>&nbsp;&nbsp;<font color="#6f6f6f">Cureus</font>
